Quotables
"Without question, the greatest invention in the history of mankind is beer. Oh, I grant you that the wheel was also a fine invention, but the wheel does not go nearly as well with pizza."
Dave Barry
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7422764 | Matrix-forming composition containing pectin A liquid edible composition with a pH of more than 6, a viscosity below 600 mPas at a shear rate of 100s-1 and 20° C., and a viscosity of at least 125% of the aforementioned viscosity at a pH below 5 and a temperature of 37° C., the composition comprising at least... | 09/09/2008 |
| 7268161 | Comprehensive pharmacologic therapy for treatment of obesity including cysteine The comprehensive pharmacologic therapy for treatment of obesity including Cysteine is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementa... | 09/11/2007 |
| 6863904 | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoi... | 03/08/2005 |
| 6764692 | Method to treat laminitis and reduce dietary intake for horses A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administerin... | 07/20/2004 |
| 6660777 | Comprehensive pharmacologic therapy for treatment of obesity The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for... | 12/09/2003 |
| 6656473 | Tryptophan source from plants and uses thereof Compositions are described comprising at least partially defatted meal from a plant source containing protein-bound tryptophan, preferably squash seeds, and, optionally, a carbohydrate source provided in an amount capable of facilitating transport of in v... | 12/02/2003 |
| 6552087 | Therapeutic agent comprising (+)-sibutramine The use of (+)-sibutramine in the treatment of depression, obesity, Parkinson's disease, cerebral function disorders and diabetes is described.... | 04/22/2003 |
| 6528502 | Composition and method for improved carbohydrate management in mammals A nutritional supplement for use in managing carbohydrates and enhancing anabolism in mammals is described. The nutritional supplement contains regulated amounts of niacin, chromium, and vanadium, and optionally thiamin, riboflavin, magnesium, and zinc. T... | 03/04/2003 |
| 6384088 | Comprehensive pharmacologic therapy for treatment of obesity The comprehensive pharmacologic therapy for treatment of obesity is a procedure which involves the administration of a desired therapeutic range of Diethylpropion and/or Phentermine in combination with a SSRI medication and nutritional supplementation for... | 05/07/2002 |
| 6162805 | Use of an NK-1 receptor antagonist and an SSRI for treating obesity The present invention relates to the use of an NK-1 receptor antagonist and a selective serotonin reuptake inhibitor for the treatment or prevention of obesity.... | 12/19/2000 |
| 6008242 | Use of 1-centchroman for the manufacture of a pharmaceutical composition for the treatment of obesity The present invention provides novel uses of compounds of general formula I ##STR1## wherein R1, R4 and R5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lo... | 12/28/1999 |
| 5980952 | Pharmaceutical composition for the programmed release of dexfenfluramine A novel pharmaceutical composition allowing the programmed release of dexfenfluramine containing a water-soluble acid addition salt of dexfenfluramine on a mixture of minigranules, both rapid release and slow release minigranules, permits the attainment o... | 11/09/1999 |
| 5972974 | Transdermal nicotine metabolites and human body weight A therapeutic method is provided to manage human body weight in nicotine-experienced or nicotine-naive individuals, comprising of transdermally administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in ne... | 10/26/1999 |
| 5945455 | Amine and amidine containing compounds as weight reducing agents Use of amine and amidine containing compounds of formula (I) such as galegine and related substituted amine and amidine containing compounds as agents for reducing weight in mammals, pharmaceutical formulations containing a compound of formula (I) and met... | 08/31/1999 |
| 5911992 | Method for controlling weight with hypericum perforatum and garcinia cambogia A method of controlling weight in mammals by orally administering to the mammal an amount of a pharmaceutical composition containing Hypericum perforatum or active components thereof effective to control the weight of the mammal is described. The pharmace... | 06/15/1999 |
| 5869503 | Nicotine metabolites and human body weight A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicot... | 02/09/1999 |
| 5847008 | Method of treating diabetes and related disease states The instant invention is concerned with acetylphenols which are useful as antiobesity and antidiabetic compounds. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering or modulating triglyceride le... | 12/08/1998 |
| 5776983 | Catecholamine surrogates useful as ଲ3 agonists Compounds of the formula ##STR1## or pharmaceutically acceptable salts thereof wherein: A is a bond, --(CH2)n -- or --CH(B)--, where n is an integer of 1 to 3 and B is --CN, --CON(R9)R9' or --CO2... | 07/07/1998 |
| 5753253 | Composition and method for inducing satiety A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingre... | 05/19/1998 |
| 5573774 | Nicotine metabolites, nicotine dependence and human body weight A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicot... | 11/12/1996 |
| 5543405 | Composition and method for weight reduction and long term management of obesity A weight reduction composition comprises a sympathomimetic agent and a mineral cation salt or chelate capable of enhancing carbohydrate metabolism, protein or fatty acid synthesis, retarding protein breakdown or lowering serum cholesterol levels such as t... | 08/06/1996 |
| 5498424 | Method of treating obesity The present invention provides a simple, pharmacological method for treating obesity without risk of undesirable side effects. It has been discovered that intake of a megadose of a macrolide antibiotic creates an anorexigenic reaction in the human suffici... | 03/12/1996 |
| 5494894 | Agent for the regulation of the appetite or a sleeping agent An agent for the regulation of the appetite or a sleeping agent, which consists of the activation peptide in procolipase, consisting of the peptide sequence X-Pro-Y-Pro-Arg wherein a) X is Ala and Y is Gly, or b) X is Val and Y is Asp, or a derivative thereof.... | 02/27/1996 |
| 5462742 | Gel-forming liquid dietary fibre composition A dietary fibre composition comprising a water-soluble, nononic cellulose ether having a cloud point not higher than 35° C. in combination with a charged surfactant and optional additives in water, the ratio of surfactant to cellulose ether being 1:5 to ... | 10/31/1995 |
| 5436272 | Treatment of obesity N,N-dimethyl-1-[ 1-(4-chlorophenyl)cyclobutyl] -3-methylbutylamine hydrochloride is used in the treatment of obesity in humans.... | 07/25/1995 |
| 5426120 | Pharmaceutical composition containing γ-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders γ-Hydroxybutyric acid and its physiologically equivalent forms are useful in the treatment of the syndromes of abstinence, craving and dependence on drugs, drugs of abuse, psychotropics, stupefacient and/or psychoactive substances, nicotine, or nutrition... | 06/20/1995 |
| 5352686 | Method for producing an orexigenic effect The present invention is directed to the use of esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and hexahydro-8-hydroxy-2,6-methano-2H-quinolizines in the manufacture of a medicament for producing an orexigenic effect.... | 10/04/1994 |
| 5330779 | Material for food and method for production thereof A material for food of slow digestion and absorption, characterized by comprising a starchy material having an amylose content in the range of from about 25 to about 60% by weight and a modifier for modifying said starchy material and having the enzymatic... | 07/19/1994 |
| 5322697 | Composition and method for inducing satiety A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingre... | 06/21/1994 |
| 5292722 | Intravenous solution that diminishes body protein loss The present invention provides compositions and methods of decreasing the nitrogen loss in a mammal which is normally associated with the administration of isocaloric solutions. Specifically, the present invention provides compositions comprising from abo... | 03/08/1994 |
| 5290808 | Method to control the intake of food Novel methods and compositions for the suppression of the desire for food consumption in warm-blooded animals consisting essentially of the administration of 2-phenyl-1,3-propanediol dicarbamate are disclosed.... | 03/01/1994 |
| 5250572 | (R)-norfluoxetine in method for occupying serotonin IC receptors The present invention provides (R)-norfluoxetine and pharmaceutically acceptable salts thereof capable of selectively occupying 5HT1c receptors.... | 10/05/1993 |
| 5250571 | (S)-norfluoxetine in method of inhibiting serotonin uptake The present invention provides (S)-norfluoxetine and pharmaceutically acceptable salts thereof capable of inhibiting the uptake of serotonin.... | 10/05/1993 |
| 5234945 | Method of producing body weight and food intake using a dopamine D2 receptor agonist This invention provides a method for treating the symptoms of obesity which comprises administering to a human or other mammal suffering from the symptoms of obesity an effective amount of a compound selected from the group consisting of the optically act... | 08/10/1993 |
| 5223484 | Peptide which regulates weight gain in mammals A dodecapeptide for regulating weight gain in mammals, as defined in the sequence: CHHRKKGYADLY wherein C is cysteine, H is histidine, R is arginine, K is lysine, G is glycine, Y is tyrosine, A is alanine, D is aspartic acid and L is leucine; and the rema... | 06/29/1993 |
| 5084475 | Methods for suppressing the endocrine system Cobalt protoporphyrin and cobalt mesoporphyrin are administered to animals to achieve weight loss and improve protein to fat ratio.... | 01/28/1992 |
| 5055460 | Method for weight loss A method for producing or maintaining weight loss by administering to a human a composition containing an effective amount of each of caffine, aspirin and ephedrine. The pharmaceutical composition can be administered concurrently with caloric restriction ... | 10/08/1991 |
| 5017619 | Phenethanolamine derivatives The invention is directed to phenethanolamine derivatives and their pharmaceutically compatible salts, having the formula ##STR1## wherein n is the number 1 or 2; L1 and L2 are hydrogen, C1-3 -(alkyl)carbonyl or C | 05/21/1991 |
| 4956388 | 3-aryloxy-3-substituted propanamines The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.... | 09/11/1990 |
| 4935225 | Appetite suppresant dentifrice An appetite suppressant oral composition containing Benzocaine, high impact flavor and a sweetening agent, in the form of a dental cream or a mouthspray. A novel method of reducing appetite and thereby intended for controlling weight of consumers, which c... | 06/19/1990 |
